- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01150435
Driving Ability of Drug Dependant Patients in Maintenance Therapy
"Mobility" is a contributing factor in today's society. Drug dependence displays not only a medical but also an economic problem: Especially for an intended reintegration of a drug dependant patient in maintenance therapy the possession of a driving licence could be decisive for a job allocation and therefore the intended reintegration to society.
Subject of this study was to verify if patients under substitution therapy with R, S- Methadone, S- Methadone, Buprenorphine and Buprenorphine plus Naloxone are just as fit to drive a car as a non drug dependent person.
For this investigation we compared 121 drug dependent patients in stable maintenance therapy for a minimum of two years without consumption of any other psychotropic substances than their maintenance drug (including THC) with non- drug dependant subjects of the same gender, age and level of education.
This is the largest study on this topic worldwide. The neuro- cognitive working order was tested by means of the "Vienna Test System" an objective, reliable and valid test quantifying reaction time, attention efficiency, concentration, maximum resilience and orientation. Current use of any other psychotropic substance or alcohol just as any serious illness (including psychiatric diseases, except for an effectively treated depression) lead to exclusion from this study.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Baveria
-
Munich, Baveria, Germany, 80336
- Institut für Rechtsmedizin
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Drug dependent patients in stable maintenance therapy for a minimum of two years without consumption of any other psychotropic substances than their maintenance drug (including THC)
- Written agreement on attending this study after full clarification
- majority
Exclusion Criteria:
- Patients, who do not approve or are not able to approve, to this study
- Patients, who are not legally competent
- Patients in emergency situations
- Patients under age
- Consumption of any other psychotropic substances than the maintenance drug
- Severe illnesses p.e. malignant diseases, serious psychiatric illness
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Buprenorphine
|
|
Maintenance Medication D, S- Methadon
|
|
Maintenance Medication S- Methadon
|
|
Buprenorphine+ Naloxone
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Thomas Gilg, Proffessor, Institut für Rechtsmedizin München
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Hummel 2010-1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Driving Ability
-
Stefan LakämperPsychiatric University Hospital, Zurich; Swiss Federal Institute of Technology...RecruitingADHD | Driving Simulator Performance | Driving Behavior | ADHD - Attention Deficit Disorder With Hyperactivity | Driving AbilitySwitzerland
-
University of PennsylvaniaGeneral Motors (GM)CompletedDistracted Driving | Impaired Driving | Driving BehaviorsUnited States
-
University of PennsylvaniaProgressive Auto InsuranceCompletedDriving Impaired | Distracted DrivingUnited States
-
University of PennsylvaniaCompleted
-
Rush University Medical CenterCompletedImpairment | Driving | Intoxication | Alcohol Impaired DrivingUnited States
-
University of BernETH Zurich; University of St.GallenRecruitingDriving Under the Influence | Cannabis-impaired DrivingSwitzerland
-
University of Wisconsin, MadisonCompleted
-
Seoul National University HospitalRecruitingAutomobile DrivingKorea, Republic of
-
University of LiegeCompleted
-
Naurex, Inc, an affiliate of Allergan plcCompleted